Larvol Delta - Asher-Bio-to-Unveil-Two-New-Immunotherapy-Programs-a-CD8-T-Cell-Targeted-IL21-and-a-CisTargeted-IL2-for-Cell-Therapy-Augmentation-at-AACR-Annual-Meeting

AB821 - Asher Biotherap

https://www.businesswire.com/news/home/20220408005075/en/%C2%A0Asher-Bio-to-Unveil-Two-New-Immunotherapy-Programs-a-CD8-T-Cell-Targeted-IL-21-and-a-Cis-Targeted-IL-2-for-Cell-Therapy-Augmentation-at-AACR-Annual-Meeting

Apr 8, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next